Table 1 Baseline characteristics of the study participants.
Pancreatic cancer | ||||
|---|---|---|---|---|
No (n = 1089708) | Yes (n = 4124) | P value | ||
Age (years), mean ± SD | 49.1 ± 13.4 | 61.7 ± 10.8 | < 0.001 | |
Age groups, years, n (%) | ||||
20–40 | 290,545 (26.7) | 131 (3.2) | < 0.001 | |
40–64 | 637,037 (58.5) | 2192 (53.2) | ||
≥ 65 | 162,126 (14.9) | 1801 (43.7) | ||
Sex, n (%) | < 0.001 | |||
Men | 798,218 (73.3) | 2695 (65.4) | ||
Women | 291,490 (26.7) | 1429 (34.6) | ||
Smoking, n (%) | < 0.001 | |||
Never | 517,424 (47.5) | 2204 (53.4) | ||
Former | 203,519 (18.7) | 791 (19.2) | ||
Current | 368,765 (33.8) | 1129 (27.4) | ||
Alcohol consumption, n (%) | < 0.001 | |||
None | 503,467 (46.2) | 2373 (57.5) | ||
Light-to-moderate | 586,241 (53.8) | 1751 (42.5) | ||
Regular exercise, n (%) | 197,388 (18.1) | 825 (20.0) | 0.002 | |
Low income (< 25%), n (%) | 211,197 (19.4) | 914 (22.2) | < 0.001 | |
Anthropometrics, mean ± SD | ||||
BMI (kg/m2) | 26.4 ± 2.8 | 26.2 ± 2.8 | < 0.001 | |
Waist circumference (cm) | 88.0 ± 6.6 | 89.1 ± 6.8 | < 0.001 | |
Systolic BP (mm Hg) | 127.6 ± 14.6 | 130.7 ± 15.7 | < 0.001 | |
Diastolic BP (mm Hg) | 79.7 ± 9.8 | 80.2 ± 10.1 | < 0.001 | |
Laboratory findings, mean ± SD | ||||
Fasting glucose (mg/dL) | 102.8 ± 28.5 | 109.6 ± 34.0 | < 0.001 | |
Total cholesterol (mg/dL) | 206.9 ± 38.0 | 203.8 ± 40.0 | < 0.001 | |
HDL cholesterol (mg/dL) | 51.2 ± 30.6 | 51.9 ± 34.4 | 0.206 | |
LDL cholesterol (mg/dL) | 118.0 ± 42.3 | 115.6 ± 40.1 | < 0.001 | |
Triglycerides (mg/dL) | 176.2 (176.0–176.4) | 170.3 (167.8–172.8) | < 0.001 | |
eGFR (mL/min/1.73 m2) | 85.4 ± 46.8 | 81.8 ± 41.4 | < 0.001 | |
Comorbidities, n (%) | ||||
Diabetes mellitus | 153,172 (14.1) | 1094 (26.5) | < 0.001 | |
Hypertension | 411,436 (37.8) | 2366 (57.4) | < 0.001 | |
Dyslipidemia | 305,485 (28.0) | 1386 (33.6) | < 0.001 | |
CKD | 89,572 (8.2) | 597 (14.5) | < 0.001 | |
Pancreatitis | 748 (0.07) | 8 (0.19) | 0.002 | |
Cholangitis | 208 (0.02) | 3 (0.07) | 0.007 | |
